KAM
Krensavage Asset Management Portfolio holdings
AUM
$189M
This Quarter Return
+19.53%
1 Year Return
+19.71%
3 Year Return
+56.44%
5 Year Return
+120.01%
10 Year Return
+215.64%
AUM
$368M
AUM Growth
+$368M
(+18%)
Cap. Flow
+$5.7M
Cap. Flow
% of AUM
1.55%
Top 10 Holdings %
Top 10 Hldgs %
98.88%
Holding
13
New
–
Increased
6
Reduced
5
Closed
2
Top Buys
| 1 |
Biogen
BIIB
|
$10.9M |
| 2 |
Alkermes
ALKS
|
$7.7M |
| 3 |
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
|
$5.8M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$3.48M |
| 5 |
Enanta Pharmaceuticals
ENTA
|
$3.15M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$8.8M |
| 2 |
United Therapeutics
UTHR
|
$8.12M |
| 3 |
AnaptysBio
ANAB
|
$5.79M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$4.44M |
| 5 |
McKesson
MCK
|
$332K |
Sector Composition
| 1 | Healthcare | 98.48% |
| 2 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
United Therapeutics
UTHR
$13.8B
| $57.2M | 15.56% | 472,548 -67,098 | -12% | -$8.12M |
|
|
ALXN
2
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $55.4M | 15.06% | 493,170 +31,032 | +7% | +$3.48M |
|
|
3
Regeneron Pharmaceuticals
REGN
$61.5B
| $49.7M | 13.52% | 79,691 -7,126 | -8% | -$4.44M |
|
|
4
Biogen
BIIB
$19.4B
| $40.5M | 11.02% | 151,420 +40,649 | +37% | +$10.9M |
|
|
5
Enanta Pharmaceuticals
ENTA
$180M
| $38.3M | 10.42% | 763,103 +62,785 | +9% | +$3.15M |
|
|
TARO
6
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $34.7M | 9.43% | 521,507 +34,232 | +7% | +$2.28M |
|
|
7
McKesson
MCK
$85.4B
| $33.2M | 9.02% | 216,142 -2,164 | -1% | -$332K |
|
|
8
Alkermes
ALKS
$4.78B
| $30.4M | 8.26% | 1,564,665 +397,034 | +34% | +$7.7M |
|
|
SRGA
9
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $18.6M | 5.06% | 5,851,572 +1,823,800 | +45% | +$5.8M |
|
|
IVC
10
DELISTED
Invacare Corporation
IVC
| $5.58M | 1.52% | 876,421 -10,825 | -1% | -$69K |
|
|
11
AnaptysBio
ANAB
$569M
| $4.13M | 1.12% | 184,846 -259,031 | -58% | -$5.79M |
|
|
12
Gilead Sciences
GILD
$140B
| – | – | -117,755 | Closed | -$8.8M |
|
|
CHNG
13
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| – | – | -3,639 | Closed | -$36K |
|